Quality and composition of archived nucleic acids after use in SARS-CoV-2 molecular testing

Ho Hyun Song,Jong Cheul Choi,Ran Lee,Sook Kyung Yoon,Hye Jeong Park,Young Hee Shin,Jeong Won Shin,Jieun Kim
DOI: https://doi.org/10.1016/j.cca.2023.117755
IF: 6.314
2024-01-05
Clinica Chimica Acta
Abstract:Background Reverse transcription real-time PCR (rRT-PCR) has been a gold-standard method to detect SARS-CoV-2, for which quality assessment of nucleic acids (NAs) is not needed. In order to prepare for future use, we evaluated NA quality from archived SARS-CoV-2 rRT-PCR samples. Methods NA samples were collected in February 2021 and extracted using the QIAamp DSP Virus Spin Kit, (53 SARS-CoV-2-positive and 100 SARS-CoV-2-negative). Quality, quantity, and purity of NA were measured spectrophotometrically or fluorescently. Droplet digital PCR was used to characterize the double strand DNA (dsDNA) origin and composition by quantifying 16 s rDNA and RPP30 . Results The RIN and purity were not significantly different between groups ( p = 0.3828 ). RNA quantity was significantly higher than dsDNA in both groups ( p < 0.0001 ); both dsDNA and RNA quantity were significantly higher in positive samples (dsDNA, RNA p = 0.021 ). For dsDNA, 16 s rDNA copies were significantly greater than RPP30 in both groups ( p < 0.0001 ), and RPP30 were significantly higher in positive samples ( p < 0.0001 ). Conclusions Archived NA quality after SARS-CoV-2 RT-PCR was guaranteed for subsequent molecular use, especially for short targets and human or bacterial DNA.
medical laboratory technology
What problem does this paper attempt to address?